<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2023</volume><submitter>Guo K</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>According to American Joint Committee on Cancer (AJCC) 8th staging system, T1 intrahepatic cholangiocarcinoma (T1 ICC) is considered a tumor with no vascular invasion. However, T1 ICC usually occurs distant metastasis (DM), and the clinical features of these patients could help clinicians identify the high-risk population.&lt;h4>Methods&lt;/h4>We reviewed 1959 newly diagnosed patients with T1 ICC from the Surveillance, Epidemiology, and End Results (SEER) database during 2004-2018. Logistic regression models and Cox proportional hazards models were conducted to predict the risk of DM and overall survival (OS), respectively, and then, web-based nomograms were constructed. Decision curve analysis (DCA) and clinical impact curves (CIC) were used to measure the clinical utility of</pubmed_abstract><journal>BioMed research international</journal><pagination>6638755</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9873431</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Predictors of Distant Metastasis and Prognosis in Newly Diagnosed T1 Intrahepatic Cholangiocarcinoma.</pubmed_title><pmcid>PMC9873431</pmcid><pubmed_authors>Guo K</pubmed_authors><pubmed_authors>Lou Y</pubmed_authors><pubmed_authors>Zheng S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Predictors of Distant Metastasis and Prognosis in Newly Diagnosed T1 Intrahepatic Cholangiocarcinoma.</name><description>&lt;h4>Background&lt;/h4>According to American Joint Committee on Cancer (AJCC) 8th staging system, T1 intrahepatic cholangiocarcinoma (T1 ICC) is considered a tumor with no vascular invasion. However, T1 ICC usually occurs distant metastasis (DM), and the clinical features of these patients could help clinicians identify the high-risk population.&lt;h4>Methods&lt;/h4>We reviewed 1959 newly diagnosed patients with T1 ICC from the Surveillance, Epidemiology, and End Results (SEER) database during 2004-2018. Logistic regression models and Cox proportional hazards models were conducted to predict the risk of DM and overall survival (OS), respectively, and then, web-based nomograms were constructed. Decision curve analysis (DCA) and clinical impact curves (CIC) were used to measure the clinical utility of</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-22T06:16:06.442Z</modification><creation>2025-04-05T21:40:12.926Z</creation></dates><accession>S-EPMC9873431</accession><cross_references><pubmed>36704724</pubmed><doi>10.1155/2023/6638755</doi></cross_references></HashMap>